These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 9137677

  • 21. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G, PITAGORA Study Investigators.
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [Abstract] [Full Text] [Related]

  • 22. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V, Ickrath O, Seipel L.
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [Abstract] [Full Text] [Related]

  • 23. [Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
    Hermida JS, Mabo P, Rouesnel P, Scheck F, Canler A, Barthélémy M, Wanszelbaum H.
    Ann Cardiol Angeiol (Paris); 1995 Jan; 44(1):49-55. PubMed ID: 7702357
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E, Denjoy I.
    Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
    [Abstract] [Full Text] [Related]

  • 25. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H, Andersson T, Fengsrud E, Friberg L, Linde P, Rosenqvist M, Englund A.
    J Intern Med; 2011 Sep 25; 270(3):281-90. PubMed ID: 21635583
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP.
    Arch Mal Coeur Vaiss; 1995 Dec 25; 88(12):1869-74. PubMed ID: 8729368
    [Abstract] [Full Text] [Related]

  • 28. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
    Turco P, De Simone A, La Rocca V, El Jamal B, Nocerino P, Astarita C, De Matteis C, Messina V, Greco L, Rotunno R, Di Napoli T, Vitale DF, Stabile G.
    Pacing Clin Electrophysiol; 2005 Jan 25; 28 Suppl 1():S124-7. PubMed ID: 15683478
    [Abstract] [Full Text] [Related]

  • 29. Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment.
    Riva S, Tondo C, Carbucicchio C, Galimberti P, Fassini G, Della Bella P.
    Europace; 1999 Oct 25; 1(4):242-7. PubMed ID: 11220561
    [Abstract] [Full Text] [Related]

  • 30. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
    Romano S, Fattore L, Toscano G, Corsini F, Coppo A, Catanzaro M, Romano A, Martone A, Caccavale F, Iodice E, Di Maggio O, Corsini G.
    Ital Heart J Suppl; 2001 Jan 25; 2(1):41-5. PubMed ID: 11216083
    [Abstract] [Full Text] [Related]

  • 31. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D, Ishibashi K, Sakai R, Inoue M, Omori I, Asayama J, Nakagawa M.
    Kokyu To Junkan; 1992 Dec 25; 40(12):1203-8. PubMed ID: 1480832
    [Abstract] [Full Text] [Related]

  • 32. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug 25; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul 25; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 36. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 25; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 37. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P, Botto GL, Baldi N.
    Ital Heart J Suppl; 2005 Jun 25; 6(6):335-40. PubMed ID: 16013424
    [Abstract] [Full Text] [Related]

  • 38. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T, Yomogida K, Nakamura S, Suzuki O, Horiuchi D, Kameda K, Tomita H, Abe N, Owada S, Oikawa K, Okumura K.
    J Cardiol; 2003 Sep 25; 42(3):111-7. PubMed ID: 14526660
    [Abstract] [Full Text] [Related]

  • 39. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May 25; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

  • 40. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T, Nakamura S, Suzuki O, Yomogida K, Horiuchi D, Abe N, Kameda K, Owada S, Tomita H, Oikawa K, Okumura K.
    J Cardiol; 2003 Apr 25; 41(4):191-8. PubMed ID: 12728540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.